Episode 288 | Chance Leonard & Dr. Sean Churchill, Genesis Innovation Group | Create It, Make It, Sell It: Building Medtech Companies That Win
1 hr 2 min
What does it take to get a medtech idea to "the top of Mount Everest," and back down safely? In this episode, Duane Mancini sits down with the two leaders of Genesis Innovation Group, a development partner that has taken founders from first sketch to exit again and again. Dr. Sean Churchill is a former engineer turned shoulder surgeon who co-founded a startup that was acquired three times over, from Tornier to Wright Medical to Stryker, then built Genesis so he and his engineers could keep moving at startup speed. He also leads cultivate(MD), a fund of about 175 investors, nearly half of them physicians, who once saved him from a deal that GLP-1 drugs were about to make obsolete. Chance Leonard, a former Division I wrestler with 31 years in medtech, spent nearly 15 years at Synthes and led Stanmore Implants to a Stryker acquisition before stepping in as Genesis CEO two and a half years ago. Together they get into why every company has to create a product, make a product and sell a product with excellence; how switching one startup's indication turned into a far bigger exit; how to tell good feedback from noise; why "smart money" means a seat on the board and a weekly call; and the 37-minute internal clock that taught Sean how trust is really built. If you're building in medtech, this is a masterclass in doing it with discipline, humility and no tolerance for mediocrity. Chance Leonard LinkedIn Dr. Sean Churchill LinkedIn Genesis Innovation Group Website Genesis Innovation Group LinkedIn cultivate(MD) Website Duane Mancini LinkedIn Project Medtech LinkedIn Project Medtech Website Thank you to our sponsors: Ward Law, Wheelhouse DMG, and JumpStart Inc.